Rural Health
Resources by Topic: Statistics and data
Key Findings from the Evaluation of the Tribal HPOG 2.0 Program, 2015-2020
Features an evaluation of the Tribal Health Profession Opportunity Grant 2.0 Program. Highlights funded programs, their service areas, and participant data pertaining to healthcare education, training, and employment.
Date: 09/2021
Sponsoring organizations: Administration for Children and Families, Office of Planning, Research, and Evaluation
view details
Features an evaluation of the Tribal Health Profession Opportunity Grant 2.0 Program. Highlights funded programs, their service areas, and participant data pertaining to healthcare education, training, and employment.
Date: 09/2021
Sponsoring organizations: Administration for Children and Families, Office of Planning, Research, and Evaluation
view details
Wisconsin PDO Grant Final Report: Prescription Drug/Opioid Overdose-Related Deaths Prevention Project
Reports on the outcomes of the Wisconsin Prescription Drug/Opioid Overdose-Related Death Prevention (PDO) project grant award from the Substance Abuse and Mental Health Services Administration (SAMHSA). Includes statistics on the rural and urban counties selected to receive the project services such as estimated population with opioid use disorder (OUD), poverty, and more. Describes project activities and strategies focused on reducing the number of opioid-related deaths and adverse events, developing and implementing secondary prevention programs, and providing overdose survivors and their families with services and support within 72 hours of overdose.
Author(s): Kylie Lafayette, Elizabeth Feder, Tom Bently
Date: 09/2021
Sponsoring organization: University of Wisconsin Population Health Institute
view details
Reports on the outcomes of the Wisconsin Prescription Drug/Opioid Overdose-Related Death Prevention (PDO) project grant award from the Substance Abuse and Mental Health Services Administration (SAMHSA). Includes statistics on the rural and urban counties selected to receive the project services such as estimated population with opioid use disorder (OUD), poverty, and more. Describes project activities and strategies focused on reducing the number of opioid-related deaths and adverse events, developing and implementing secondary prevention programs, and providing overdose survivors and their families with services and support within 72 hours of overdose.
Author(s): Kylie Lafayette, Elizabeth Feder, Tom Bently
Date: 09/2021
Sponsoring organization: University of Wisconsin Population Health Institute
view details
Wisconsin Final Report: Strategic Prevention Framework for Prescription Drugs (SPF Rx)
Reports the outcomes of the Strategic Prevention Framework for Prescription Drugs (SPF Rx) project grant award from the Substance Abuse and Mental Health Services Administration (SAMHSA) for the state of Wisconsin. Describes activities and strategies focused in rural Dodge and Sauk counties to reduce prescription opioid drug misuse, build local coalitions to address prevention needs, and establish a statewide surveillance system to monitor prescription opioid misuse.
Author(s): Elizabeth Feder, Kylie Lafayette
Date: 09/2021
Sponsoring organization: University of Wisconsin Population Health Institute
view details
Reports the outcomes of the Strategic Prevention Framework for Prescription Drugs (SPF Rx) project grant award from the Substance Abuse and Mental Health Services Administration (SAMHSA) for the state of Wisconsin. Describes activities and strategies focused in rural Dodge and Sauk counties to reduce prescription opioid drug misuse, build local coalitions to address prevention needs, and establish a statewide surveillance system to monitor prescription opioid misuse.
Author(s): Elizabeth Feder, Kylie Lafayette
Date: 09/2021
Sponsoring organization: University of Wisconsin Population Health Institute
view details
Prenatal Alcohol and Other Drug Exposures in Child Welfare Study: Final Report
Reports the findings of a study examining 22 child welfare agencies in 5 states to determine how agencies obtain information about prenatal substance exposure (PSE) when a child is involved with the child welfare system and how agencies use PSE information to provide services and support for affected children and their families. Exhibit 4 describes the characteristics and key features of the states and child welfare agencies involved in the study, including a breakdown of rural and urban counties.
Author(s): E. Ingoldsby, T. Richards, K. Usher, et al.
Date: 09/2021
Sponsoring organization: Administration for Children and Families
view details
Reports the findings of a study examining 22 child welfare agencies in 5 states to determine how agencies obtain information about prenatal substance exposure (PSE) when a child is involved with the child welfare system and how agencies use PSE information to provide services and support for affected children and their families. Exhibit 4 describes the characteristics and key features of the states and child welfare agencies involved in the study, including a breakdown of rural and urban counties.
Author(s): E. Ingoldsby, T. Richards, K. Usher, et al.
Date: 09/2021
Sponsoring organization: Administration for Children and Families
view details
Inequities in the Geographic Accessibility of COVID-19 Biomedical Therapeutic Trials in the United States
Research report examining geographic proximity to COVID-19 biomedical therapeutic trial sites, breaking down U.S. clinical trial data by rural/urban location, age, and race/ethnicity. Charts depict drive times to trial sites for each demographic group, comparing rural and urban populations.
Author(s): Rohan Khazanchi, Samuel D. Powers, Elizabeth T. Rogawski McQuade, Kathleen A. McManus
Citation: Journal of General Internal Medicine
Date: 09/2021
view details
Research report examining geographic proximity to COVID-19 biomedical therapeutic trial sites, breaking down U.S. clinical trial data by rural/urban location, age, and race/ethnicity. Charts depict drive times to trial sites for each demographic group, comparing rural and urban populations.
Author(s): Rohan Khazanchi, Samuel D. Powers, Elizabeth T. Rogawski McQuade, Kathleen A. McManus
Citation: Journal of General Internal Medicine
Date: 09/2021
view details
An Evaluation of Telehealth Use by Medicare Beneficiaries in 2020
Research brief examining telehealth use for outpatient evaluation and management from January 2019 to December 2020 based on a 20% sample of fee-for-service Medicare beneficiaries. Charts monthly trends for in-person and telehealth visits and compares rural and urban telehealth use, offering policy implications related to rural access to services.
Author(s): Chad Ellimoottil, Ziwei Zhu, Rod Dunn, et al.
Date: 09/2021
Sponsoring organization: University of Michigan Institute for Healthcare Policy and Innovation
view details
Research brief examining telehealth use for outpatient evaluation and management from January 2019 to December 2020 based on a 20% sample of fee-for-service Medicare beneficiaries. Charts monthly trends for in-person and telehealth visits and compares rural and urban telehealth use, offering policy implications related to rural access to services.
Author(s): Chad Ellimoottil, Ziwei Zhu, Rod Dunn, et al.
Date: 09/2021
Sponsoring organization: University of Michigan Institute for Healthcare Policy and Innovation
view details
Outcome Comparison of High-Risk Native American Patients Who Did or Did Not Receive Monoclonal Antibody Treatment for COVID-19
Results of a monoclonal antibody (mAb) treatment program for high-risk Native American patients at a rural acute care facility on the Fort Apache Indian Reservation in eastern Arizona. Features demographics and statistics comparing 30-day outcomes among patients who did or did not receive mAb treatment between December 2020 and February 2021.
Author(s): Ryan M. Close, T. Shaifer Jones, Christopher Jentoft, James B. McAuley
Citation: JAMA Network Open, 4(9)
Date: 09/2021
view details
Results of a monoclonal antibody (mAb) treatment program for high-risk Native American patients at a rural acute care facility on the Fort Apache Indian Reservation in eastern Arizona. Features demographics and statistics comparing 30-day outcomes among patients who did or did not receive mAb treatment between December 2020 and February 2021.
Author(s): Ryan M. Close, T. Shaifer Jones, Christopher Jentoft, James B. McAuley
Citation: JAMA Network Open, 4(9)
Date: 09/2021
view details
Asthma Surveillance — United States, 2006–2018
Reports on asthma prevalence by population demographics, poverty level, and geographic location, including rural and metro comparisons. Examines trends based on 2006-2018 data from the National Heath Interview Survey (NHIS), National Vital Statistics System (NVSS), and the National Center for Health Statistics (NCHS).
Author(s): Cynthia A. Pate, Hatice S. Zahran, Xiaoting Qin, et al.
Citation: MMWR (Morbidity and Mortality Weekly Report), 70(5), 1-32
Date: 09/2021
Sponsoring organization: Centers for Disease Control and Prevention
view details
Reports on asthma prevalence by population demographics, poverty level, and geographic location, including rural and metro comparisons. Examines trends based on 2006-2018 data from the National Heath Interview Survey (NHIS), National Vital Statistics System (NVSS), and the National Center for Health Statistics (NCHS).
Author(s): Cynthia A. Pate, Hatice S. Zahran, Xiaoting Qin, et al.
Citation: MMWR (Morbidity and Mortality Weekly Report), 70(5), 1-32
Date: 09/2021
Sponsoring organization: Centers for Disease Control and Prevention
view details
Reenvisioning Rural America
Examines census tracts designated as micropolitan, small town, and isolated rural by the U.S. Department of Agriculture's Rural-Urban Commuting Area (RUCA) code system, offering a typology of tracts based on assets and strengths. Organizes rural census tracts into categories including accessible, energy-rich hubs; high-employment agricultural areas; centers of wealth and health; and more. Includes a data map with information on each category of rural census tract and population, government, and geographic information for each tract.
Date: 09/2021
Sponsoring organization: Urban Institute
view details
Examines census tracts designated as micropolitan, small town, and isolated rural by the U.S. Department of Agriculture's Rural-Urban Commuting Area (RUCA) code system, offering a typology of tracts based on assets and strengths. Organizes rural census tracts into categories including accessible, energy-rich hubs; high-employment agricultural areas; centers of wealth and health; and more. Includes a data map with information on each category of rural census tract and population, government, and geographic information for each tract.
Date: 09/2021
Sponsoring organization: Urban Institute
view details
Utilization of Z Codes for Social Determinants of Health among Medicare Fee-for-Service Beneficiaries, 2019
Discusses how Z codes help report and track social determinants of health and reduce health disparities. Describes Z code claim data collected from 2016-2019, including the top 5 Z codes used in 2019 and the propositions of Medicare beneficiaries with Z codes across demographic characteristics. Highlights potential strategies to increase Z code utilization.
Date: 09/2021
Sponsoring organization: Centers for Medicare and Medicaid Services
view details
Discusses how Z codes help report and track social determinants of health and reduce health disparities. Describes Z code claim data collected from 2016-2019, including the top 5 Z codes used in 2019 and the propositions of Medicare beneficiaries with Z codes across demographic characteristics. Highlights potential strategies to increase Z code utilization.
Date: 09/2021
Sponsoring organization: Centers for Medicare and Medicaid Services
view details